Lipigon Pharmaceuticals AB (publ) (FRA:9RP)
Germany
· Delayed Price · Currency is EUR 0.0010
-0.0024 (-70.59%)
At close: Dec 5, 2025
FRA:9RP Revenue
Lipigon Pharmaceuticals AB had revenue of 32.00K SEK in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to 881.00K, down -90.71% year-over-year. In the year 2024, Lipigon Pharmaceuticals AB had annual revenue of 10.29M, down -37.30%.
Revenue (ttm)
881.00K SEK
Revenue Growth
-90.71%
P/S Ratio
5.57
Revenue / Employee
125.86K SEK
Employees
7
Market Cap
663.60K EUR
Revenue Chart
* This company reports financials in SEK.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Rheinmetall AG | 11.00B |
| Deutsche Bank Aktiengesellschaft | 29.86B |